Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey
Andrea Taddio(University of Trieste), Gabriele Simonini(Meyer Children's Hospital), Alessandro Consolaro(Istituto Giannina Gaslini), Roberta Caorsi(University of Milan), Alessandra Meneghel(University of Padua), Sara Della Paolera(University of Trieste), Alberto Villani(University of Milan), Lucio Verdoni(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Fiammetta Zunica(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Francesco La Torre(Ospedale Vito Fazzi), Claudia Bracaglia(Bambino Gesù Children's Hospital), Rolando Cimaz(Meyer Children's Hospital), Davide Montin(University of Padua), Maria Cristina Maggio(Hospital Universitario Santa Cristina), Gianvincenzo Zuccotti(University of Milan), Marco Cattalini(University of Brescia), Rita Sottile(Istituto Giannina Gaslini), Manuela Giangreco(IRCCS Materno Infantile Burlo Garofolo), Rosa Maria Dellepiane(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alessandra Marchesi(Meyer Children's Hospital), Marianna Fabi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), A Ravelli(University of Trieste)
Cited by 126
Related Papers
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
|Frontiers in Pharmacology|2019|616
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease
|Nature Genetics|2011|355
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases
|Autoimmunity Reviews|2021|330
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
|Journal of Clinical Investigation|2019|238